会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Antimicrobial theta defensins and methods of using same
    • 抗微生物θ防御素及其使用方法
    • US07399823B1
    • 2008-07-15
    • US10009317
    • 2000-05-10
    • Michael E. SelstedYi-Quan TangJun YuanAndre J. Ouellette
    • Michael E. SelstedYi-Quan TangJun YuanAndre J. Ouellette
    • A61K38/00
    • C07K7/08A61K38/12C07K14/4723C12P21/00Y02A50/473Y02A50/481
    • The present invention relates to an isolated cyclic peptide, theta defensin, having antimicrobial activity, and to theta defensin analogs. A theta defensin can have the amino acid sequence Xaa1-Xaa2-Xaa3-Xaa4-Xaa5-Xaa1-Xaa6-Xaa4-Xaa4-Xaa1-Xaa1-Xaa6-Xaa4-Xaa5-Xaa1-Xaa3-Xaa7-Xaa8, wherein Xaa1 to Xaa8 are defined; wherein Xaa1 can be linked through a peptide bond to Xaa8; and wherein crosslinks can be formed between Xaa3 and Xaa3, between Xaa5 and Xaa5, and between Xaa7 and Xaa7. For example, the invention provides a theta defensin having the amino acid sequence Gly-Phe-Cys-Arg-Cys-Leu-Cys-Arg-Arg-Gly-Val-Cys-Arg-Cys-Ile-Cys-Thr-Arg (SEQ ID NO:1), wherein the Gly at position 1 (Gly-1) is linked through a peptide bond to Arg-18, and wherein disulfide bonds are present between Cys-3 and Cys-16, between Cys-5 and Cys-14, and between Cys-7 and Cys-12. The invention also provides nucleic acids encoding theta defensins and antibodies that specifically bind a theta defensin. In addition, the invention relates to methods of using theta defensin to reduce or inhibit microbial growth or survival.
    • 本发明涉及具有抗微生物活性的分离的环肽,θ防御素,以及θ防御素类似物。 θ防御素可以具有氨基酸序列Xaa1-Xaa2-Xaa3-Xaa4-Xaa5-Xaa1-Xaa6-Xaa4-Xaa4-Xaa1-Xaa1-Xaa6-Xaa4-Xaa5-Xaa1-Xaa3-Xaa7-Xaa8,其中Xaa1至Xaa8是 定义 其中Xaa1可通过肽键与Xaa8连接; 并且其中可以在Xaa3和Xaa3之间,Xaa5和Xaa5之间以及Xaa7和Xaa7之间形成交联。 例如,本发明提供具有氨基酸序列Gly-Phe-Cys-Arg-Cys-Leu-Cys-Arg-Arg-Gly-Val-Cys-Arg-Cys-Ile-Cys-Thr-Arg的θ防御素 SEQ ID NO:1),其中位置1处的Gly(Gly-1)通过肽键与Arg-18连接,并且其中二硫键存在于Cys-3和Cys-16之间,Cys-5和Cys之间 -14,以及Cys-7和Cys-12之间。 本发明还提供编码θ防御素和特异性结合θ防御素的抗体的核酸。 此外,本发明涉及使用θ防御素来减少或抑制微生物生长或存活的方法。
    • 2. 发明授权
    • Antimicrobial theta defensins and methods of using same
    • 抗微生物θ防御素及其使用方法
    • US06890537B2
    • 2005-05-10
    • US10313994
    • 2002-12-05
    • Michael E. SelstedYi-Quan TangJun YuanAndre J. Ouellette
    • Michael E. SelstedYi-Quan TangJun YuanAndre J. Ouellette
    • A61K38/00A61K38/10A61K38/12C07K7/08C07K14/47C12N15/12C12P21/00A61K39/00A61K39/38
    • C07K7/08A61K38/12C07K14/4723C12P21/00Y02A50/473Y02A50/481
    • The present invention relates to an isolated cyclic peptide, theta defensin, having antimicrobial activity, and to theta defensin analogs. A theta defensin can have the amino acid sequence Xaa1-Xaa2-Xaa3-Xaa4-Xaa5-Xaa1-Xaa6-Xaa4-Xaa4-Xaa1-Xaa1-Xaa6-Xaa4-Xaa5-Xaa1-Xaa3-Xaa7-Xaa5, wherein Xaa1 to Xaa8 are defined; wherein Xaa1 can be linked through a peptide bond to Xaa8; and wherein crosslinks can be formed between Xaa3 and Xaa3, between Xaa5 and Xaa5, and between Xaa7 and Xaa7. For example, the invention provides a theta defensin having the amino acid sequence Gly-Phe-Cys-Arg-Cys-Leu-Cys-Arg-Arg-Gly-Val-Cys-Arg-Cys-Ile-Cys-Thr-Arg (SEQ ID NO:1), wherein the Gly at position 1 (Gly-1) is linked through a peptide bond to Arg-18, and wherein disulfide bonds are present between Cys-3 and Cys-16, between Cys-5 and Cys-14, and between Cys-7 and Cys-12. The invention also relates to antibodies that specifically bind a theta defensin and to isolated nucleic acid molecules encoding a theta defensin. In addition, the invention relates to methods of using theta defensin or a theta defensin analog to reduce or inhibit microbial growth or survival in an environment capable of sustaining microbial growth or survival by contacting the environment with the theta defensin.
    • 本发明涉及具有抗微生物活性的分离的环肽,θ防御素,以及θ防御素类似物。 θ防御素可以具有氨基酸序列Xaa1-Xaa2-Xaa3-Xaa4-Xaa5-Xaa1-Xaa6-Xaa4-Xaa4-Xaa1-Xaa1-Xaa6-Xaa4-Xaa5-Xaa1-Xaa3-Xaa7-Xaa5,其中Xaa1至Xaa8是 定义 其中Xaa1可通过肽键与Xaa8连接; 并且其中可以在Xaa3和Xaa3之间,Xaa5和Xaa5之间以及Xaa7和Xaa7之间形成交联。 例如,本发明提供具有氨基酸序列Gly-Phe-Cys-Arg-Cys-Leu-Cys-Arg-Arg-Gly-Val-Cys-Arg-Cys-Ile-Cys-Thr-Arg的θ防御素 SEQ ID NO:1),其中位置1处的Gly(Gly-1)通过肽键与Arg-18连接,并且其中二硫键存在于Cys-3和Cys-16之间,Cys-5和Cys之间 -14,以及Cys-7和Cys-12之间。 本发明还涉及特异性结合θ防御素和编码θ防御素的分离的核酸分子的抗体。 此外,本发明涉及使用θ防御素或θ防御素类似物以通过使环境与θ防御素接触来在能够维持微生物生长或存活的环境中减少或抑制微生物生长或存活的方法。
    • 4. 发明授权
    • Antimicrobial theta defensins and methods of using same
    • 抗微生物θ防御素及其使用方法
    • US06335318B1
    • 2002-01-01
    • US09309487
    • 1999-05-10
    • Michael E. SelstedYi-Quan TangJun YuanAndre J. Ouellette
    • Michael E. SelstedYi-Quan TangJun YuanAndre J. Ouellette
    • A61K3800
    • C07K7/08A61K38/12C07K14/4723C12P21/00Y02A50/473Y02A50/481
    • The present invention relates to an isolated cyclic peptide, theta defensin, having antimicrobial activity, and to theta defensin analogs. A theta defensin can have the amino acid sequence Xaa1-Xaa2-Xaa3-Xaa4-Xaa5-Xaa1-Xaa6-Xaa4-Xaa4-Xaa1-Xaa1-Xaa6-Xaa4-Xaa5 -Xaa1-Xaa3-Xaa7-Xaa5, wherein Xaa1 to Xaa8 are defined; wherein Xaa1 can be linked through a peptide bond to Xaa8; and wherein crosslinks can be formed between Xaa3 and Xaa3, between Xaa5 and Xaa5, and between Xaa7 and Xaa7. For example, the invention provides a theta defensin having the amino acid sequence Gly-Phe-Cys-Arg-Cys-Leu-Cys-Arg-Arg-Gly-Val-Cys-Arg-Cys-Ile-Cys-Thr-Arg (SEQ ID NO:1), wherein the Gly at position 1 (Gly-1) is linked through a peptide bond to Arg-18, and wherein disulfide bonds are present between Cys-3 and Cys-16, between Cys-5 and Cys-14, and between Cys-7 and Cys-12. The invention also relates to antibodies that specifically bind a theta defensin and to isolated nucleic acid molecules encoding a theta defensin. In addition, the invention relates to methods of using theta defensin or a theta defensin analog to reduce or inhibit microbial growth or survival in an environment capable of sustaining microbial growth or survival by contacting the environment with the theta defensin.
    • 本发明涉及具有抗微生物活性的分离的环肽,θ防御素,以及θ防御素类似物。 θ防御素可以具有氨基酸序列Xaa1-Xaa2-Xaa3-Xaa4-Xaa5-Xaa1-Xaa6-Xaa4-Xaa4-Xaa1-Xaa1-Xaa6-Xaa4-Xaa5 -Xaa1-Xaa3-Xaa7-Xaa5,其中Xaa1至Xaa8是 定义 其中Xaa1可通过肽键与Xaa8连接; 并且其中可以在Xaa3和Xaa3之间,Xaa5和Xaa5之间以及Xaa7和Xaa7之间形成交联。 例如,本发明提供具有氨基酸序列Gly-Phe-Cys-Arg-Cys-Leu-Cys-Arg-Arg-Gly-Val-Cys-Arg-Cys-Ile-Cys-Thr-Arg的θ防御素 SEQ ID NO:1),其中位置1处的Gly(Gly-1)通过肽键与Arg-18连接,并且其中二硫键存在于Cys-3和Cys-16之间,Cys-5和Cys之间 -14,以及Cys-7和Cys-12之间。 本发明还涉及特异性结合θ防御素和编码θ防御素的分离的核酸分子的抗体。 此外,本发明涉及使用θ防御素或θ防御素类似物以通过使环境与θ防御素接触来在能够维持微生物生长或存活的环境中减少或抑制微生物生长或存活的方法。
    • 5. 发明申请
    • Antimicrobial theta defensins and methods of using same
    • 抗微生物θ防御素及其使用方法
    • US20050261193A1
    • 2005-11-24
    • US11126468
    • 2005-05-10
    • Michael SelstedYi-Quan TangJun YuanAndre Ouellette
    • Michael SelstedYi-Quan TangJun YuanAndre Ouellette
    • A61K38/00A61K38/10A61K38/12C07K7/08C07K14/47C12N15/12C12P21/00
    • C07K7/08A61K38/12C07K14/4723C12P21/00Y02A50/473Y02A50/481
    • The present invention relates to an isolated cyclic peptide, theta defensin, having antimicrobial activity, and to theta defensin analogs. A theta defensin can have the amino acid sequence Xaa1-Xaa2-Xaa3-Xaa4-Xaa5-Xaa1-Xaa6-Xaa4-Xaa4-Xaa1-Xaa1-Xaa6-Xaa4-Xaa5-Xaa1-Xaa3-Xaa7-Xaa5, wherein Xaa1 to Xaa8 are defined; wherein Xaa1 can be linked through a peptide bond to Xaa8; and wherein crosslinks can be formed between Xaa3 and Xaa3, between Xaa5 and Xaa5, and between Xaa7 and Xaa7. For example, the invention provides a theta defensin having the amino acid sequence Gly-Phe-Cy-Arg-Cys-Leu-Cys-Arg-Arg-Gly-Val-Cys-Arg-Cys-Ile-Cys-Thr-Arg (SEQ ID NO:1), wherein the Gly at position 1 (Gly-1) is linked through a peptide bond to Arg-18, and wherein disulfide bonds are present between Cys-3 and Cys-16, between Cys-5 and Cys-14, and between Cys-7 and Cys-12. The invention also relates to antibodies that specifically bind a theta defensin and to isolated nucleic acid molecules encoding a theta defensin. In addition, the invention relates to methods of using theta defensin or a theta defensin analog to reduce or inhibit microbial growth or survival in an environment capable of sustaining microbial growth or survival by contacting the environment with the theta defensin.
    • 本发明涉及具有抗微生物活性的分离的环肽,θ防御素,以及θ防御素类似物。 θ防御素可以具有氨基酸序列Xaa1-Xaa2-Xaa3-Xaa4-Xaa5-Xaa1-Xaa6-Xaa4-Xaa4-Xaa1-Xaa1-Xaa6-Xaa4-Xaa5-Xaa1-Xaa3-Xaa7-Xaa5,其中Xaa1至Xaa8是 定义 其中Xaa1可通过肽键与Xaa8连接; 并且其中可以在Xaa3和Xaa3之间,Xaa5和Xaa5之间以及Xaa7和Xaa7之间形成交联。 例如,本发明提供具有氨基酸序列Gly-Phe-Cy-Arg-Cys-Leu-Cys-Arg-Arg-Gly-Val-Cys-Arg-Cys-Ile-Cys-Thr-Arg的θ防御素 SEQ ID NO:1),其中位置1处的Gly(Gly-1)通过肽键与Arg-18连接,并且其中二硫键存在于Cys-3和Cys-16之间,Cys-5和Cys之间 -14,以及Cys-7和Cys-12之间。 本发明还涉及特异性结合θ防御素和编码θ防御素的分离的核酸分子的抗体。 此外,本发明涉及使用θ防御素或θ防御素类似物以通过使环境与θ防御素接触来在能够维持微生物生长或存活的环境中减少或抑制微生物生长或存活的方法。
    • 8. 发明授权
    • Bioconjugates of synthetic apelin polypeptides
    • 合成apelin多肽的生物缀合物
    • US09340582B2
    • 2016-05-17
    • US14336290
    • 2014-07-21
    • Jun YuanFrederic ZecriPhilipp GroscheHongjuan ZhaoEric PetersShari Lynn CaplanChanggang Lou
    • Jun YuanFrederic ZecriPhilipp GroscheHongjuan ZhaoEric PetersShari Lynn CaplanChanggang Lou
    • C07K14/47C07K7/08A61K47/48A61K45/06A61K38/10C07K16/00A61K39/395
    • A61K38/10A61K38/00A61K45/06A61K47/542A61K47/643A61K47/68A61K47/6811C07K14/47C07K14/765C07K2319/30C07K2319/31
    • The invention provides a bioconjugates comprising a synthetic polypeptide of Formula I′ (SEQ ID NO: 1): or an amide, an ester or a salt thereof, wherein X1, X2, X3, X4, X5, X6, X7, X8, X9, X10, X11, X12 and X13 are defined herein and a half-life extending moiety wherein the peptide and the half-life extending moiety are covalently linked or fuse, optionally via a linker. The polypeptides are agonist of the APJ receptor. The invention also relates to a method for manufacturing the bioconjugates of the invention, and its therapeutic uses such as treatment or prevention of acute decompensated heart failure (ADHF), chronic heart failure, pulmonary hypertension, atrial fibrillation, Brugada syndrome, ventricular tachycardia, atherosclerosis, hypertension, restenosis, ischemic cardiovascular diseases, cardiomyopathy, cardiac fibrosis, arrhythmia, water retention, diabetes (including gestational diabetes), obesity, peripheral arterial disease, cerebrovascular accidents, transient ischemic attacks, traumatic brain injuries, amyotrophic lateral sclerosis, burn injuries (including sunburn) and preeclampsia. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
    • 本发明提供包含式I'(SEQ ID NO:1)的合成多肽的生物缀合物或其酰胺,其酯或其盐,其中X 1,X 2,X 3,X 4,X 5,X 6,X 7,X 8,X 9 ,X10,X11,X12和X13在本文中定义并且半衰期延长部分,其中肽和半衰期延长部分任选地经由连接体共价连接或融合。 多肽是APJ受体的激动剂。 本发明还涉及本发明的生物缀合物的制备方法及其治疗用途,例如治疗或预防急性失代偿性心力衰竭(ADHF),慢性心力衰竭,肺动脉高压,心房颤动,布鲁加达综合征,室性心动过速,动脉粥样硬化 ,高血压,再狭窄,缺血性心血管疾病,心肌病,心脏纤维化,心律失常,保水,糖尿病(包括妊娠糖尿病),肥胖,外周动脉疾病,脑血管意外,短暂性脑缺血发作,创伤性脑损伤,肌萎缩性侧索硬化,烧伤( 包括晒伤)和先兆子痫。 本发明还提供药理活性剂和药物组合物的组合。